- Marketwired•19 days ago
Theratechnologies Acquires Commercial Rights to Ibalizumab in the European Union and Four Additional Territories
Theratechnologies Inc. is pleased to announce that it has reached an agreement with TaiMed Biologics, Inc. for the acquisition of the commercial rights to ibalizumab in the European Union, Israel, Norway, ...
- Marketwired•24 days ago
Theratechnologies Holds Investment Community Meeting and Provides Updated Financial Guidance for Its Fiscal Year 2017
Theratechnologies Inc. today announced that it hosted a webcast meeting for the investment community. The purpose of the meeting was to provide the investment community with its corporate strategy for ...
- Marketwired•29 days ago
Theratechnologies Inc. announced today that it will host an Investment Community Webcast on March 1, 2017, at 9:00 a.m. , and should conclude at approximately 11:00 a.m. .
TH.TO : Summary for THERATECHNOLOGIES - Yahoo Finance
Theratechnologies Inc. (TH.TO)
Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||5.70 - 6.00|
|52 Week Range||1.73 - 6.00|
|PE Ratio (TTM)||966.67|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|